| Structure | Chemical Name | CAS | MF |
|
apocytochrome c550
|
|
|
|
|
APOCYNUMVENETUMEXTRACTPOWDER
|
|
|
|
Apocynol A
|
358721-33-2
|
C13H20O3
|
|
A-OXO-IMIDAZO[1,2-A]PYRIDINE-3-PROPANOIC ACID ETHYL ESTER
|
152831-79-3
|
C12H12N2O3
|
|
|
AQEE-30 (mouse, rat)
|
323185-80-4
|
C156H245N47O56
|
|
|
Apoenzymes
|
|
|
|
|
apo-dystrophin 3
|
|
|
|
|
apo-dystrophin 2
|
|
|
|
|
apoferredoxin
|
|
|
|
|
apo-dystrophin 1
|
|
|
|
|
APOFERRITIN
|
9013-31-4
|
NULL
|
|
|
APO(EPA)
|
|
|
|
|
ApoE Real Time Reagent set for Rotorgene Platform
|
|
|
|
|
ApoE Real Time Reagent set.
|
|
|
|
Apogalanthamine
|
26955-02-2
|
C16H17NO2
|
|
|
apoflavodoxin
|
|
|
|
|
APOGELSEMINE
|
|
|
|
|
Apn1 protein, S cerevisiae
|
|
|
|
|
apoHDL-sepharose
|
|
|
|
apogossypolic acid
|
4741-50-8
|
C13H16O6
|
|
apohemanthamine
|
6900-81-8
|
C16H15NO3
|
|
|
apohemoglobin
|
|
|
|
APOGOSSYPOL HEXAACETATE
|
105201-55-6
|
C40H42O12
|
|
apogossypol
|
66389-74-0
|
C28H30O6
|
|
APP 201-533
|
80390-90-5
|
C12H12N2O
|
|
APP721-770
|
|
C261H404N72O79S3
|
|
|
APP2
|
|
|
|
APP714-770
|
|
C297H469N79O88S3
|
|
|
APP717
|
|
|
|
|
AOX SAMPLE PREPARATION SET 25 TESTS SPEC
|
|
|
|
|
APO-2 (HUMAN) CDNA PROBE
|
|
|
|
|
APO-1 (HUMAN):HULG FUSION PROTEIN
|
|
|
|
|
APO-1 (HUMAN):HULG FUSION PROTEIN BIOTIN
|
|
|
|
|
APO-J, 46-60 [C-], BETA CHAIN, HUMAN
|
|
|
|
APOHYOSCINE
|
535-26-2
|
C17H19NO3
|
|
|
AOX STANDARD
|
|
|
|
|
AOX standard (p-Chlorophenol) - 200 mg Cl/L in Water
|
|
|
|
|
AOX STANDARD 0.2 - 2.0 MG/L SPECTROQUANT
|
|
|
|
|
apolactoferrin
|
|
|
|
|
APO-LACTOFERRIN, HUMAN
|
|
|
|
|
APOLAR CAPILLARY COLUMN TEST MIXTURE 2
|
|
|
|
|
APP-β （Amyloid protein precursor695/770 ）
|
|
|
|
|
APP695 （Amyloid protein precursor）
|
|
|
|
|
appA protein, E coli
|
|
|
|
|
AppA protein
|
|
|
|
|
AppA2 protein
|
|
|
|
|
APO-1L (HUMAN)-MUCD8 FUSION PROTEIN BIOTIN
|
|
|
|
|
APO-1L (HUMAN) CDNA PROBE
|
|
|
|
|
APO-1L (HUMAN)-MUCD8 FUSION PROTEIN
|
|
|
|
|
Apparatus
|
|
|
|
|
APOLIPROTEIN A-IV
|
|
|
|
|
apolipoprotein A-I binding protein
|
|
|
|
|
Apolipoprotein A1 (HDL), Sheep anti-Human
|
|
|
|
|
apolipophorin III
|
|
|
|
|
Apolipoprotein A1 (HDL), CD95, FAS, Clone: DX2, Mab anti-Human, FITC
|
|
|
|
|
apolipoprotein E1 Baden
|
|
|
|
|
apolipoprotein E receptor 2
|
|
|
|
|
APOLIPOPROTEIN AI FRAGMENT [HOMO SAPIENS]
|
|
C43H58N10O15
|
|
|
APOLIPOPROTEINB(LDL),GOATANTI-
|
|
|
|
|
APOLIPOPROTEINB(LDL),CLONE:069-03,MABANTI-HUMAN:ELISA
|
|
|
|
|
Apolipoproteins C
|
|
|
|
|
ApolipoproteinSaa(ApoSaa),Recombinant
|
|
|
|
|
ApolipoproteinAi(ApoAi),Human
|
|
|
|
|
apolipoprotein A-I Zaragoza
|
|
|
|
|
ApolipoproteinCiii(ApoCiii)
|
|
|
|
|
ApolipoproteinD(ApoD)
|
|
|
|
|
Apolipoprotein(A)(Apo(A))-LdlAdsorbed/PlasminogenStripped
|
|
|
|
|
apolipoprotein J-high density lipoprotein
|
|
|
|
|
ApolipoproteinAi(ApoAi),Mouse
|
|
|
|
|
ApolipoproteinB-48/100(ApoB-48/100)
|
|
|
|
|
apolipoprotein B-32
|
|
|
|
|
Apolipoprotein A & B (HDL & LDL), Goat anti-Human
|
|
|
|
|
Apolipoproteins B
|
|
|
|
|
apolipoprotein CII St Michael
|
|
|
|
|
ApolipoproteinE(ApoE),Hamster
|
|
|
|
|
Apolipoprotein C-II, Human Plasma, VLDL
|
|
|
|
|
Apolipoprotein B, Human Plasma, LDL
|
|
|
|
|
ApolipoproteinAi(ApoAi),Hamster
|
|
|
|
|
Apolipoprotein E, Isoform E3, Human, Recomb.
|
|
|
|
|
apolipoprotein L
|
|
|
|
|
apolipoprotein II
|
|
|
|
|
apolipoprotein E-5 (Lys(3))
|
|
|
|
|
apolipoprotein A-I Tangier
|
|
|
|
|
apolipoprotein C-II (Toronto)
|
107497-50-7
|
|
|
|
Apolipoprotein A1 analog (HDL), fragment, Human
|
|
|
|
|
Apolipoprotein A1 (HDL), Human
|
|
|
|
|
apolipoprotein E-3 Leiden
|
|
|
|
|
Apolipoproteins E
|
|
|
|
|
apolipoprotein A-I Helsinki
|
|
|
|
|
apolipoprotein A-II isoproteins
|
|
|
|
|
ApolipoproteinCi(ApoCi)
|
|
|
|
|
ApolipoproteinE(ApoE)
|
|
|
|
|
ApolipoproteinB(ApoB)
|
|
|
|
|
APOLIPOPROTEIN
|
|
|
|
|
apolipoprotein VLDL II
|
|
|
|
|
apolipoprotein E-1
|
|
|
|
|
apolipoprotein A-I Milano
|
|
|
|
|
apolipoprotein A-V
|
|
|
|
|
Apolipoprotein A1 (HDL), CD95, FAS, Clone: FAS18, Mab anti-Human, Induces Apoptosis
|
|
|
|
|
APOLIPOPROTEIN A1 PRECURSOR FRAGMENT [HOMO SAPIENS]
|
|
C68H115N15O20
|